Pain News and Research

Latest Pain News and Research

Dendritic cells play a novel protective role in pancreas

NYU Langone Medical Center researchers have discovered the novel protective role dendritic cells play in the pancreas. The new study, published in the November issue of journal Gastroenterology, shows dendritic cells can safeguard the pancreas against acute pancreatitis, a sudden dangerous swelling and inflammation of the pancreas gland.

23 Nov 2011

In Colo. and Mass., worries about health care impact of super committee's failure

"Uncertainty" was a word used repeatedly Monday by Colorado economists and industries in lamenting the failure of the congressional super committee ... Health care is another area with super committee consequences, resulting "in millions of dollars in reduced Medicare payments to Colorado providers for many years to come" by restricting access, Steven Summer, president of the Colorado Hospital Association, said in a statement.

23 Nov 2011

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Celgene International Sàrl, a subsidiary of Celgene Corporation, announced that based on the recommendation from the Data Monitoring Committee (DMC) it will discontinue its pivotal double-blinded Phase III MAINSAIL trial that was designed to evaluate the efficacy and safety of docetaxel and prednisone with or without lenalidomide in patients with castrate-resistant prostate cancer.

23 Nov 2011

Holiday health tips for cancer survivors

Surviving the holidays with one's waistline, bank account and sanity intact can be challenging for everyone, but the season affords specific pitfalls - and opportunities - for cancer survivors who are mindful of staying healthy throughout the season and beyond.

23 Nov 2011

FDA approves Medtronic's iPro2 Professional continuous glucose monitoring system

Medtronic, Inc. today announced the Food and Drug Administration (FDA) approval of iPro2, a next generation Professional continuous glucose monitoring (CGM) system and the latest in a series of recent diabetes technology approvals and innovations from the company.

From Medtronic 22 Nov 2011

FDA accepts Regeneron's ARCALYST sBLA for review

Regeneron Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Company's supplemental Biologics License Application (sBLA) for ARCALYST Injection for Subcutaneous Use for the prevention of gout flares in patients initiating uric acid-lowering therapy.

22 Nov 2011

PAREXEL implements fMRI technology in early phase CNS drug development

PAREXEL International, a leading global biopharmaceutical services provider, today announced that it has enhanced its central nervous system (CNS) capabilities for clinical development through the implementation of functional magnetic resonance imaging (fMRI) technology in its Early Phase units.

From Parexel 22 Nov 2011

Cognitive-behavioral therapy safe and effective for juvenile fibromyalgia

A recent trial shows cognitive-behavioral therapy (CBT) reduces functional disability and depressive symptoms in adolescents with juvenile fibromyalgia. The psychological intervention was found to be safe and effective, and proved to be superior to disease management education.

22 Nov 2011

CHRI third quarter revenues increase 219% to $9.3 million

China Health Resource, Inc., a producer and supplier of Traditional Chinese Medicine (TCM) products, announced robust record breaking quarterly earnings for September 2011.

22 Nov 2011

New device safe, more effective for patients with chronic neurological conditions

Functional electrical stimulation (FES) was developed to help return lost function to patients with upper and lower extremity injuries and spinal cord injuries, among other applications. However, the devices, which work by stimulating neuronal activity in nerve-damaged patients, have a potential shortcoming in that the electrical currents needed for the treatment to work can also send errant signals to surrounding nerves, resulting in painful side effects.

22 Nov 2011

WSU receives NHLBI grant to develop new CF treatments

A Wayne State University research team led by Fei Sun, Ph.D., assistant professor of physiology in the School of Medicine, recently received a grant with an anticipated amount of nearly $1.9 million from the National Heart, Lung and Blood Institute of the National Institutes of Health to better understand how this defective protein in cystic fibrosis patients is prematurely digested.

22 Nov 2011

New way to enhance effects of anandamide in the body

UC Irvine and Italian researchers have discovered a new means of enhancing the effects of anandamide - a natural, marijuana-like chemical in the body that provides pain relief.

22 Nov 2011

Psychological problems can influence patient's viewpoint of IBS symptom severity

A patient's viewpoint of the severity of irritable bowel syndrome (IBS) symptoms can be influenced not only by physical symptoms of IBS but broader psychological problems, according to a new study in Clinical Gastroenterology and Hepatology, the official journal of the American Gastroenterological Association.

22 Nov 2011

New insights into immune-system changes that may trigger cartilage breakdown

Challenging long-held notions that osteoarthritis is a result mainly of wear and tear on the joints, researchers led by Dr. William H. Robinson of the Department of Veterans Affairs Palo Alto Health Care System and Stanford University have provided new insights into the immune-system changes that may trigger cartilage breakdown.

21 Nov 2011

FDA approves Abbott's new Chagas in vitro diagnostic test

Abbott received approval from the U.S. Food and Drug Administration (FDA) for a new Chagas in vitro diagnostic test.

21 Nov 2011

The untold stories of children of sperm donors

From Jennifer Lahl and The Center for Bioethics and Culture, producers of the award-winning Eggsploitation (2010), Anonymous Father's Day presents the untold stories of children of sperm donors.

21 Nov 2011

Australia's TGA grants market authorisation for Pierre Fabre Médicament's milnacipran to treat fibromyalgia

The Therapeutic Goods Administration (TGA), Australia's regulatory body for therapeutic products, granted Pierre Fabre Médicament's milnacipran market authorisation for the treatment of fibromyalgia.

21 Nov 2011

UTHealth and Memorial Hermann HVI first in Houston to implant FDA approved artificial heart valve

Cardiologists and cardiovascular surgeons at The University of Texas Health Science Center at Houston and Memorial Hermann Heart & Vascular Institute are the first in Houston to implant the artificial heart valve recently approved by the Food and Drug Administration, as well as a newer, smaller version that is part of a clinical trial.

21 Nov 2011

Impax initiates patent challenge related to Fentora

Impax Laboratories, Inc. today confirms that it has initiated a challenge of the patents listed in the Orange Book in connection with Fentora® (fentanyl buccal tablets, 100 mcg, 200 mcg, 400 mcg, 600 mcg and 800 mcg).

21 Nov 2011

Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes

Celgene International Sàrl, a subsidiary of Celgene Corporation, today announced that REVLIMID (lenalidomide) has been granted approval by the Swiss agency for Therapeutic Products (Swissmedic) for use in patients with transfusion-dependent anemia due to low-or intermediate-1-risk myelodysplastic syndromes (MDS) associated with a deletion 5q cytogenic abnormality with or without additional cytogenic abnormalities.

21 Nov 2011

Pain News and Research

Latest Pain News and Research

Dendritic cells play a novel protective role in pancreas

In Colo. and Mass., worries about health care impact of super committee's failure

Celgene to discontinue docetaxel and prednisone plus lenalidomide Phase III trial on CRPC

Holiday health tips for cancer survivors

FDA approves Medtronic's iPro2 Professional continuous glucose monitoring system

FDA accepts Regeneron's ARCALYST sBLA for review

PAREXEL implements fMRI technology in early phase CNS drug development

Cognitive-behavioral therapy safe and effective for juvenile fibromyalgia

CHRI third quarter revenues increase 219% to $9.3 million

New device safe, more effective for patients with chronic neurological conditions

WSU receives NHLBI grant to develop new CF treatments

New way to enhance effects of anandamide in the body

Psychological problems can influence patient's viewpoint of IBS symptom severity

New insights into immune-system changes that may trigger cartilage breakdown

FDA approves Abbott's new Chagas in vitro diagnostic test

The untold stories of children of sperm donors

Australia's TGA grants market authorisation for Pierre Fabre Médicament's milnacipran to treat fibromyalgia

UTHealth and Memorial Hermann HVI first in Houston to implant FDA approved artificial heart valve

Impax initiates patent challenge related to Fentora

Swissmedic approves REVLIMID for treatment of myelodysplastic syndromes

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Pain News and Research

Latest Pain News and Research

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Newsletters you may be interested in